Kasper Recourt

The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder

Kasper Recourt, Peter de Boer, Rob Zuiker et al. · Translational Psychiatry · 2019 · 74 citations · Full text

Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial

Kasper Recourt, Jasper van der Aart, Gabriël E. Jacobs et al. · Journal of Psychopharmacology · 2020 · 57 citations

Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder

Kasper Recourt, Peter de Boer, Peter van der Ark et al. · Translational Psychiatry · 2023 · 51 citations · Full text

A Study of Novel Exploratory Tools, Digital Technologies, and Central Nervous System Biomarkers to Characterize Unipolar Depression

Oleksandr Sverdlov, Jelena Curcic, Kristín Hannesdóttir et al. · Frontiers in Psychiatry · 2021 · 40 citations · Full text

Perceived barriers and facilitators of structural reimbursement for remote patient monitoring, an exploratory qualitative study

Margot Rakers, Hine J.A. van Os, Kasper Recourt et al. · Health Policy and Technology · 2022 · 26 citations · Full text